Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Anti-Cancer Agents in Medicinal Chemistry
|
March 20, 2019
Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools
Lurdes Gano, Teresa Pinheiro, António P Matos, et al.
Journal of Medicinal Chemistry
|
August 24, 2023
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition
Ricardo G Teixeira, Iris C Salaroglio, Nuno F B Oliveira, et al.
Pharmaceutics
|
July 27, 2022
Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model
Leonor Côrte-Real, Ana Rita Brás, Adhan Pilon, et al.
European Journal of Medicinal Chemistry
|
November 9, 2023
Novel family of [RuCp(N,N)(P)]<sup>+</sup> compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies
Ricardo G Teixeira, János P Mészáros, Beatriz Matos, et al.
Inorganic Chemistry
|
April 4, 2018
Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential
Leonor Côrte-Real, Ricardo G Teixeira, Patrícia Gírio, et al.
European Journal of Medicinal Chemistry
|
March 4, 2019
Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs
Tiago Moreira, Rita Francisco, Elisabeta Comsa, et al.
Journal of Medicinal Chemistry
|
February 24, 2024
Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands
Ricardo G Teixeira, Alessia Stefanelli, Adhan Pilon, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Anti-Cancer Agents in Medicinal Chemistry
|
March 20, 2019
Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools
Lurdes Gano, Teresa Pinheiro, António P Matos, et al.
Journal of Medicinal Chemistry
|
August 24, 2023
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition
Ricardo G Teixeira, Iris C Salaroglio, Nuno F B Oliveira, et al.
Pharmaceutics
|
July 27, 2022
Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model
Leonor Côrte-Real, Ana Rita Brás, Adhan Pilon, et al.
European Journal of Medicinal Chemistry
|
November 9, 2023
Novel family of [RuCp(N,N)(P)]<sup>+</sup> compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies
Ricardo G Teixeira, János P Mészáros, Beatriz Matos, et al.
Inorganic Chemistry
|
April 4, 2018
Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential
Leonor Côrte-Real, Ricardo G Teixeira, Patrícia Gírio, et al.
European Journal of Medicinal Chemistry
|
March 4, 2019
Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs
Tiago Moreira, Rita Francisco, Elisabeta Comsa, et al.
Journal of Medicinal Chemistry
|
February 24, 2024
Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands
Ricardo G Teixeira, Alessia Stefanelli, Adhan Pilon, et al.
Page
of 4